Asian Institute of Medical Sciences, a distinguished super-speciality hospital based in Faridabad, India, has achieved a significant milestone by being honoured as the Best Healthcare Brand 2025 by The Economic Times (ET Now). The recognition, presented at the ET Now Best Brands Conclave, is a testament to the hospital's ongoing dedication to clinical excellence, technological leadership, and its pivotal role in elevating standards of patient care across the Asian region.

The ceremony highlighted Asian Institute's use of state-of-the-art medical innovations, particularly its investments in 3D Advanced Minimal Access Robotic Surgery. This contemporary approach enables ultra-precise procedures, minimal incisions, superior patient safety, and faster recovery times—key factors for hospital administrators and procurement teams in selecting and benchmarking advanced surgical solutions. Notably, the hospital has introduced an AI-powered Robotic Knee Replacement system, which underscores its commitment to minimally invasive orthopaedic care and rapid post-operative rehabilitation, aligning its service model to regional and global demand for value-based care and outcomes-driven performance.

This award closely follows another major accolade: Asian Institute’s recognition as one of the 'Best Organisations to Work For in 2025' by ET Edge, reflecting the institution’s investment in workforce excellence, leadership development, and culture. Facilities management and HR teams across the hospital sector may note Asian's approach to fostering workplace engagement, ethics, and innovation as a model of best practice.

Under the leadership of Chairman & Managing Director Dr. N. K. Pandey and Director Mr. Anupam Pandey, the hospital is noted for prioritizing a technology-driven clinical environment while maintaining a steadfast focus on personalized patient-centric care. The institution provides a comprehensive range of super-specialty services, including oncology, cardiology, neurosurgery, gastroenterology, liver and digestive disease management, as well as orthopaedics. In addition, it carries multiple accreditations—AACI (Association for the Accreditation of Human Research Protection Programs), NABH (National Accreditation Board for Hospitals & Healthcare Providers), and NABL (National Accreditation Board for Testing and Calibration Laboratories)—underpinning its standardization, compliance, and continuous improvement ethos.

This award comes at a critical time when healthcare organizations across Asia are intensifying their digital transformation journeys and competitive positioning within an evolving regulatory and technological framework. For business leaders, decision-makers, healthcare IT (HIT) strategists, and medical equipment suppliers, Asian Institute's achievements provide a strong reference for the successful integration of robotic systems, artificial intelligence, and data-driven patient management as indicators for future investment and partnership opportunities.

Moreover, the award reinforces the strategic necessity of advanced clinical infrastructure and workforce culture as dual engines for growth and reputation in the hospital sector. Vendors and service providers may find collaborative opportunities in the hospital’s ongoing upgrades and its openness to new technologies in imaging, diagnostics, critical care, and surgical equipment. As demand for fast, minimally invasive, and high-quality care grows, Asian Institute’s model exemplifies best-in-class adoption of next-generation technologies supporting patient safety, operational efficiency, and sustainable healthcare delivery.

For stakeholders in the region, the Asian Institute of Medical Sciences’ recognition not only underlines the relevance of strategic technology deployments and leadership commitment, but also signals where market competition and best practices are heading in the Asian hospital industry for 2025 and beyond.

Report Abuse